Imad Ajjawi
Corporate Officer/Principal at ABSCI CORPORATION
Imad Ajjawi active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ABSCI CORPORATION | Corporate Officer/Principal | 2020-12-31 | - |
Denovium, Inc.
 Denovium, Inc. Packaged SoftwareTechnology Services Part of Absci Corp., Denovium, Inc. is an American artificial intelligence company that pioneers novel AI methods to accelerate innovation in biology. Denovium is building an artificial intelligence engine (Denovium EngineTM) capable of interpreting disparate biological data types to answer biology's toughest questions. The company partners with leading biotech and pharma companies in specific areas of focus, including gene discovery, protein engineering, and genomic medicine. The company was founded by Toby H. Richardson, Ariel Schwartz, Imad Ajjawi, and Gregory Hannum, with Toby H. Richardson serving as the CEO since incorporation. Denovium was acquired by Absci Corp. on January 12, 2021 for $4 million. | Founder | - | - |
| Corporate Officer/Principal | 2018-07-31 | - |
Career history of Imad Ajjawi
Training of Imad Ajjawi
| University of California San Diego | Masters Business Admin |
| University of Nevada | Doctorate Degree |
Statistics
International
| United States | 5 |
Operational
| Corporate Officer/Principal | 2 |
| Founder | 1 |
| Masters Business Admin | 1 |
Sectoral
| Consumer Services | 3 |
| Technology Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ABSCI CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
Denovium, Inc.
Denovium, Inc. Packaged SoftwareTechnology Services Part of Absci Corp., Denovium, Inc. is an American artificial intelligence company that pioneers novel AI methods to accelerate innovation in biology. Denovium is building an artificial intelligence engine (Denovium EngineTM) capable of interpreting disparate biological data types to answer biology's toughest questions. The company partners with leading biotech and pharma companies in specific areas of focus, including gene discovery, protein engineering, and genomic medicine. The company was founded by Toby H. Richardson, Ariel Schwartz, Imad Ajjawi, and Gregory Hannum, with Toby H. Richardson serving as the CEO since incorporation. Denovium was acquired by Absci Corp. on January 12, 2021 for $4 million. | Technology Services |
- Stock Market
- Insiders
- Imad Ajjawi
- Experience
